81 related articles for article (PubMed ID: 17962792)
1. HIV-associated Castleman's disease: from case reports to evidence.
Bazeos A; Powles T; Stebbing J
J HIV Ther; 2007 Sep; 12(3):61-2. PubMed ID: 17962792
[No Abstract] [Full Text] [Related]
2. Multicentric Castleman's disease treated with combination chemotherapy and rituximab in four HIV-positive men: a case series.
Bestawros A; Michel R; Séguin C; Routy JP
Am J Hematol; 2008 Jun; 83(6):508-11. PubMed ID: 18027834
[TBL] [Abstract][Full Text] [Related]
3. [Castleman's disease, HIV and rituximab].
Valencia ME; López V; Corcuera MT; Del Val D
Rev Clin Esp; 2012 Feb; 212(2):118-9. PubMed ID: 21924712
[No Abstract] [Full Text] [Related]
4. The first reported case and management of multicentric Castleman's disease associated with Kaposi's sarcoma in an HIV-2-infected patient.
Bouvresse S; Marcelin AG; Franck N; Regnier S; Damond F; Tulliez M; Dupin N
AIDS; 2007 Jul; 21(11):1492-4. PubMed ID: 17589201
[No Abstract] [Full Text] [Related]
5. Rituximab failure in fulminant multicentric HIV/human herpesvirus 8-associated Castleman's disease with multiorgan failure: report of two cases.
Buchler T; Dubash S; Lee V; Chilton D; Cartledge J; Isaacson P; Tedder RS; Lee SM
AIDS; 2008 Aug; 22(13):1685-7. PubMed ID: 18670234
[No Abstract] [Full Text] [Related]
6. Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.
Stary G; Kohrgruber N; Herneth AM; Gaiger A; Stingl G; Rieger A
AIDS; 2008 Jun; 22(10):1232-4. PubMed ID: 18525273
[No Abstract] [Full Text] [Related]
7. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.
Gérard L; Bérezné A; Galicier L; Meignin V; Obadia M; De Castro N; Jacomet C; Verdon R; Madelaine-Chambrin I; Boulanger E; Chevret S; Agbalika F; Oksenhendler E
J Clin Oncol; 2007 Aug; 25(22):3350-6. PubMed ID: 17664482
[TBL] [Abstract][Full Text] [Related]
8. Multicentric Castleman's disease in HIV infection.
Collins LS; Fowler A; Tong CY; de Ruiter A
Int J STD AIDS; 2006 Jan; 17(1):19-24; quiz 25. PubMed ID: 16409673
[TBL] [Abstract][Full Text] [Related]
9. Multicentric Castleman's disease in a patient with HIV.
Fowler A; Collins L; de Ruiter A; Whittaker S; Kulasegaram R; Bradbeer C
Int J STD AIDS; 2006 Jan; 17(1):63-4. PubMed ID: 16409683
[TBL] [Abstract][Full Text] [Related]
10. HIV-associated multicentric Castleman's disease.
Stebbing J; Pantanowitz L; Dayyani F; Sullivan RJ; Bower M; Dezube BJ
Am J Hematol; 2008 Jun; 83(6):498-503. PubMed ID: 18260115
[TBL] [Abstract][Full Text] [Related]
11. What Is the best treatment for HIV-associated multicentric Castleman disease?
Bower M; Dalla Pria A
Clin Adv Hematol Oncol; 2012 Mar; 10(3):207-9. PubMed ID: 22402432
[No Abstract] [Full Text] [Related]
12. Involvement of human interleukin-6 in systemic manifestations of human herpesvirus type 8-associated multicentric Castleman's disease.
Foussat A; Fior R; Girard T; Boue F; Wijdenes J; Galanaud P; Emilie D
AIDS; 1999 Jan; 13(1):150-2. PubMed ID: 10207568
[No Abstract] [Full Text] [Related]
13. Low dose interferon-alpha therapy for HIV-associated multicentric Castleman's disease.
Nord JA; Karter D
Int J STD AIDS; 2003 Jan; 14(1):61-2. PubMed ID: 12590797
[TBL] [Abstract][Full Text] [Related]
14. Angiofollicular lymph node hyperplasia resembling a spinal nerve sheath tumor: a rare case of Castleman's disease.
Stevens EA; Strowd RE; Mott RT; Oaks TE; Wilson JA
Spine J; 2009 Sep; 9(9):e18-22. PubMed ID: 19482516
[TBL] [Abstract][Full Text] [Related]
15. Castleman's Disease. A Review.
Roca B
AIDS Rev; 2009; 11(1):3-7. PubMed ID: 19290029
[TBL] [Abstract][Full Text] [Related]
16. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease.
Neuville S; Agbalika F; Rabian C; Brière J; Molina JM
Am J Hematol; 2005 Aug; 79(4):337-9. PubMed ID: 16044438
[TBL] [Abstract][Full Text] [Related]
17. HHV-8 linked to Kaposi's sarcoma, Castleman's disease and primary effusion lymphoma in a HIV-1-infected man.
Bestawros A; Boulassel MR; Michel RP; Routy JP
J Clin Virol; 2008 Jun; 42(2):179-81. PubMed ID: 18343194
[No Abstract] [Full Text] [Related]
18. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease.
Casquero A; Barroso A; Fernández Guerrero ML; Górgolas M
Ann Hematol; 2006 Mar; 85(3):185-7. PubMed ID: 16341862
[TBL] [Abstract][Full Text] [Related]
19. Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease.
Montani D; Achouh L; Marcelin AG; Viard JP; Hermine O; Canioni D; Sitbon O; Simonneau G; Humbert M
Eur Respir J; 2005 Nov; 26(5):969-72. PubMed ID: 16264059
[TBL] [Abstract][Full Text] [Related]
20. Siltuximab (Sylvant) for treatment of multicentric castleman's disease.
Med Lett Drugs Ther; 2015 Jan; 57(1459):e8. PubMed ID: 25555075
[No Abstract] [Full Text] [Related]
[Next] [New Search]